Warfarin resistance due to a Val29Leu mutation in the VKORC1 protein.

被引：0
|
作者：
Huff, JD [1 ]
Lawson, HL [1 ]
Harish, VC [1 ]
Zhang, L [1 ]
Owen, J [1 ]
机构：
[1] Wake Forest Univ, Bowman Gray Sch Med, Sect Hematol & Oncol, Winston Salem, NC USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4146
引用
收藏
页码：117B / 117B
页数：1
相关论文
共 48 条
  • [21] A novel VKORC1 promoter mutation found causing warfarin resistance, along with -1639G> A promoter mutation-A pilot study on the genetic variation in patients on warfarin therapy in South India
    Shukla, Tanuj
    Reddy, Sandeep C.
    Korrapatti, Sindhupriya
    Munpally, Shesheer K.
    Tripathi, Rachana
    Dikshit, Vijay
    Rao, Kaipa Prabhakar
    BIOMARKERS AND GENOMIC MEDICINE, 2013, 5 (04) : 147 - 156
  • [22] Warfarin resistance associated with genetic polymorphism of VKORC1: linking clinical response to molecular mechanism using computational modeling
    Lewis, Benjamin C.
    Nair, Pramod C.
    Heran, Subash S.
    Somogyi, Andrew A.
    Bowden, Jeffrey J.
    Doogue, Matthew P.
    Miners, John O.
    PHARMACOGENETICS AND GENOMICS, 2016, 26 (01): : 44 - 50
  • [23] Distribution of CYP2C9 and VKORC1 Risk Alleles for Warfarin Sensitivity and Resistance in the Israeli Population
    Efrati, Edna
    Elkin, Hela
    Sprecher, Eli
    Krivoy, Norberto
    CURRENT DRUG SAFETY, 2010, 5 (03) : 190 - 193
  • [24] In vivo-assay for Warfarin-resistance by coexpression of VKORC1 and vitamin K-dependent coagulation factors
    Fregin, A.
    Rost, S.
    Mueller, C. R.
    Oldenburg, J.
    37TH HEMOPHILIA SYMPOSIUM, 2008, : 259 - +
  • [25] Novel variants in VKORC1 the target protein of Cumarin-type anticoagulants in rodents from Warfarin-resistance areas in Europe, Asia and America
    Rost, S.
    Pelz, H. -J.
    Fregin, A.
    Huenerberg, M.
    Mueller, C. R.
    Oldenburg, J.
    37TH HEMOPHILIA SYMPOSIUM, 2008, : 269 - +
  • [26] ROLE OF VKORC1 AND CYP4502C9 POLYMORHISM IN RESISTANCE TO WARFARIN THERAPY AMONG EGYPTIAN PATIENTS
    Ahmed, A.
    Goubran, H.
    Farha, M.
    Yacoub, M.
    Amin, S.
    HAEMATOLOGICA, 2013, 98 : 684 - 685
  • [27] Ethnic origin, warfarin dose and VKORC1 mutation in 300 stably warfarinised patients attending Ealing Hospital anticoagulant service
    Brito-Babapulle, F
    Harford, D
    Dosanjh, J
    Mitchell, J
    Sutton, S
    Milne, M
    Stewart, W
    Moule, S
    Abrahamson, G
    Philpott, N
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 : 84 - 84
  • [28] Human VKORC1 mutations cause variable degrees of 4-hydroxycoumarin resistance and affect putative warfarin binding interfaces
    Czogalla, Katrin J.
    Biswas, Arijit
    Wendeln, Ann-Christin
    Westhofen, Philipp
    Mueller, Clemens R.
    Watzka, Matthias
    Oldenburg, Johannes
    BLOOD, 2013, 122 (15) : 2743 - 2750
  • [29] First record of VKORC1 sequence mutation associated with resistance to anticoagulant rodenticides in Italian individuals of Mus musculus domesticus
    Iannucci, Alessio
    Natali, Chiara
    Capizzi, Dario
    Sinibaldi, Iacopo
    Sposimo, Paolo
    Ciofi, Claudio
    Fratini, Sara
    HYSTRIX-ITALIAN JOURNAL OF MAMMALOGY, 2019, 30 (02): : 183 - 185
  • [30] A vitamin K epoxide reductase complex subunit-1 (VKORC1) mutation in a patient with vitamin K antagonist resistance
    Bodin, L
    Horellou, MH
    Flaujac, C
    Loriot, MA
    Samama, MM
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (07) : 1533 - 1535
12345